The 30th anniversary meeting of the International Symposium on Endovascula Therapy (ISET) was held in February at The Diplomat hotel in Hollywood, Florida.

At the conference, Gary S. Roubin, MD, FACC received the Career Achievement Award. Roubin, who serves as Medical Director of Cardiovascular Associates (CVA), is an internationally renowned interventional cardiologist. He performed the groundbreaking work in the development of the first FDA approved coronary stent, Gianturco-Roubin Flex Stent.

He has edited 20 major textbooks on Interventional Cardiology and has published more than 240 papers and 225 abstracts in peer review journals.

Roubin earned his medical degree at the University of Queensland, Australia. He completed his residency at the Royal Prince Alfred Hospital and his fellowship at Hallstrom Institute of Cardiology in Sydney. He holds a PhD in cardiovascular physiology at Sydney University Hospital.

Roubin has served in numerous leadership roles throughout his career including Chair of Interventional Cardiac & Vascular Services at Lenox Hill in New York City for nearly a decade. He also served on faculty at Emory University School of Medicine and the UAB School of Medicine.